Solomon Moshkevich Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 day, 13 hours ago
Solomon Moshkevich has an estimated net worth of at least $39.0 million*, as of May 7, 2025. They own 139,205 shares of NTRA stock. They have sold 147,751 shares of NTRA stock since 2021, for an estimated $17.2 million.
Solomon Moshkevich $NTRA SEC Form 4 Insider Trading
Solomon Moshkevich has filed a total of 40 insider trades in $NTRA since 2021. Their most recent trade was a sale of 908 shares, made on May 01, 2025. Their largest trade was a sale of 53,489 shares, made on Apr 16, 2024. We estimate that they now own 139,205 shares of $NTRA, worth an estimated $21.8 million.
Insider Trading at $NTRA
There have been a total of 790 insider trades reported at $NTRA since 2021, with 375,220 shares purchased and 3.5 million shares sold. The most active insider traders in $NTRA stock have been Steven Leonard Chapman, Michael Burkes Brophy, and Daniel Rabinowitz. The most recent trade was a sale of 770 shares reported by Steven Leonard Chapman (CEO AND PRESIDENT), made on May 01, 2025.
History of Insider Stock Trades by Solomon Moshkevich
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
![]() |
Sale | 908 | May 01, 2025 | May 2, 2025, 9:35 p.m. |
![]() |
Sale | 331 | May 01, 2025 | May 2, 2025, 9:35 p.m. |
![]() |
Sale | 853 | May 01, 2025 | May 2, 2025, 9:35 p.m. |
![]() |
Sale | 908 | May 01, 2025 | May 2, 2025, 9:35 p.m. |
![]() |
Sale | 2,206 | Apr 28, 2025 | April 30, 2025, 9:35 p.m. |
![]() |
Sale | 292 | Apr 21, 2025 | April 22, 2025, 9:35 p.m. |
![]() |
Sale | 4 | Apr 21, 2025 | April 22, 2025, 9:35 p.m. |
![]() |
Sale | 1,291 | Apr 01, 2025 | April 3, 2025, 8:35 p.m. |
![]() |
Sale | 439 | Apr 01, 2025 | April 3, 2025, 8:35 p.m. |
![]() |
Sale | 1,270 | Apr 01, 2025 | April 3, 2025, 8:35 p.m. |
![]() |
Sale | 3 | Mar 17, 2025 | March 19, 2025, 9:35 p.m. |
![]() |
Sale | 1,023 | Mar 17, 2025 | March 19, 2025, 9:35 p.m. |
![]() |
Sale | 1,200 | Mar 05, 2025 | March 7, 2025, 10:35 p.m. |
![]() |
Sale | 1,700 | Mar 05, 2025 | March 7, 2025, 10:35 p.m. |
![]() |
Sale | 400 | Mar 05, 2025 | March 7, 2025, 10:35 p.m. |
![]() |
Sale | 2,700 | Mar 05, 2025 | March 7, 2025, 10:35 p.m. |
![]() |
Sale | 1,632 | Feb 06, 2025 | Feb. 7, 2025, 10:35 p.m. |
![]() |
Sale | 1,178 | Jan 29, 2025 | Jan. 31, 2025, 10:35 p.m. |
![]() |
Sale | 3 | Jan 29, 2025 | Jan. 31, 2025, 10:35 p.m. |
![]() |
Sale | 4,020 | Jan 29, 2025 | Jan. 31, 2025, 10:35 p.m. |
![]() |
Sale | 24,799 | Jan 22, 2025 | Jan. 24, 2025, 10:45 p.m. |
![]() |
Sale | 62 | Jan 22, 2025 | Jan. 24, 2025, 10:45 p.m. |
![]() |
Sale | 2,423 | Dec 23, 2024 | Dec. 26, 2024, 10:05 p.m. |
![]() |
Sale | 3 | Dec 23, 2024 | Dec. 26, 2024, 10:05 p.m. |
![]() |
Sale | 2 | Dec 23, 2024 | Dec. 26, 2024, 10:05 p.m. |
![]() |
Sale | 4,858 | Dec 09, 2024 | Dec. 11, 2024, 10:05 p.m. |
![]() |
Sale | 1,196 | Oct 28, 2024 | Oct. 30, 2024, 9:35 p.m. |
![]() |
Sale | 294 | Oct 21, 2024 | Oct. 23, 2024, 9:35 p.m. |
![]() |
Sale | 256 | Oct 22, 2024 | Oct. 23, 2024, 9:35 p.m. |
![]() |
Sale | 1,196 | Jul 29, 2024 | July 31, 2024, 9:05 p.m. |
![]() |
Sale | 549 | Jul 22, 2024 | July 23, 2024, 9:05 p.m. |
![]() |
Sale | 1,647 | May 28, 2024 | May 30, 2024, 9:05 p.m. |
![]() |
Sale | 1,196 | Apr 29, 2024 | May 1, 2024, 9:05 p.m. |
![]() |
Sale | 531 | Apr 23, 2024 | April 23, 2024, 9:35 p.m. |
![]() |
Sale | 53,489 | Apr 16, 2024 | April 17, 2024, 9:05 p.m. |
![]() |
Sale | 26,511 | Apr 16, 2024 | April 17, 2024, 9:05 p.m. |
![]() |
Sale | 707 | Mar 28, 2024 | March 29, 2024, 9:35 p.m. |
![]() |
Sale | 2,227 | Mar 05, 2024 | March 7, 2024, 10:40 p.m. |
![]() |
Sale | 18 | Mar 05, 2024 | March 7, 2024, 10:40 p.m. |
![]() |
Sale | 3,426 | Jan 29, 2024 | Jan. 30, 2024, 10:02 p.m. |
$NTRA Executives and Stock Owners with Insider Trades
-
Steven Leonard Chapman, CEO AND PRESIDENT
-
Michael Burkes Brophy, CHIEF FINANCIAL OFFICER
-
Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER
-
Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS
-
Matthew Rabinowitz, EXECUTIVE CHAIRMAN
-
Robert Alan Schueren, CHIEF OPERATING OFFICER
-
John Fesko, PRESIDENT, CHIEF BUS. OFFICER
-
Daniel Rabinowitz, CHIEF LEGAL OFFICER
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.